86 related articles for article (PubMed ID: 14975586)
1. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT.
Saurer TB; Carrigan KA; Ijames SG; Lysle DT
J Neuroimmunol; 2004 Mar; 148(1-2):54-62. PubMed ID: 14975586
[TBL] [Abstract][Full Text] [Related]
2. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.
Rodríguez De Fonseca F; Rubio P; Martín-Calderón JL; Caine SB; Koob GF; Navarro M
Eur J Pharmacol; 1995 Feb; 274(1-3):47-55. PubMed ID: 7768280
[TBL] [Abstract][Full Text] [Related]
3. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
Cook CD; Barrett AC; Syvanthong C; Picker MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):93-104. PubMed ID: 11041321
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
Saurer TB; Ijames SG; Lysle DT
J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
[TBL] [Abstract][Full Text] [Related]
5. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
Millan MJ; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380
[TBL] [Abstract][Full Text] [Related]
6. The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice.
Suzuki T; Maeda J; Funada M; Misawa M
Neurosci Lett; 1995 Feb; 187(1):45-8. PubMed ID: 7617299
[TBL] [Abstract][Full Text] [Related]
7. Modification of the effects of 7-OH-DPAT, a dopamine D3-receptor agonist, on morphine-induced hyperlocomotion by diabetes.
Kamei J; Saitoh A
Life Sci; 1996; 59(9):773-80. PubMed ID: 8761030
[TBL] [Abstract][Full Text] [Related]
8. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
Eltayb A; Lindblom S; Oerther S; Ahlenius S
Acta Physiol Scand; 2001 Jul; 172(3):205-9. PubMed ID: 11472307
[TBL] [Abstract][Full Text] [Related]
9. Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.
Saurer TB; Ijames SG; Carrigan KA; Lysle DT
Brain Behav Immun; 2008 Jan; 22(1):89-97. PubMed ID: 17689049
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the nucleus accumbens as a neural substrate of heroin-induced immune alterations.
Saurer TB; Ijames SG; Lysle DT
J Pharmacol Exp Ther; 2009 Jun; 329(3):1040-7. PubMed ID: 19258519
[TBL] [Abstract][Full Text] [Related]
11. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.
Saurer TB; Carrigan KA; Ijames SG; Lysle DT
J Neuroimmunol; 2006 Apr; 173(1-2):3-11. PubMed ID: 16364456
[TBL] [Abstract][Full Text] [Related]
12. 7-OH-DPAT effects on latent inhibition: low dose facilitation but high dose blockade: implications for dopamine receptor involvement in attentional processes.
Chagas-Martinich L; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2007 Mar; 86(3):441-8. PubMed ID: 17291574
[TBL] [Abstract][Full Text] [Related]
13. Ejaculation induced by i.c.v. injection of the preferential dopamine D(3) receptor agonist 7-hydroxy-2-(di-N-propylamino)tetralin in anesthetized rats.
Clément P; Bernabé J; Denys P; Alexandre L; Giuliano F
Neuroscience; 2007 Mar; 145(2):605-10. PubMed ID: 17258866
[TBL] [Abstract][Full Text] [Related]
14. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of quinpirole and 7-OH-DPAT on the spontaneous [(3)H]-dopamine efflux from rat striatal synaptosomes.
García-Sanz A; Badia A; Clos MV
Synapse; 2001 Apr; 40(1):65-73. PubMed ID: 11170223
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist.
Chu E; Chu TC; Potter DE
J Pharmacol Exp Ther; 2000 Jun; 293(3):710-6. PubMed ID: 10869368
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats.
Fecho K; Maslonek KA; Dykstra LA; Lysle DT
J Pharmacol Exp Ther; 1996 Feb; 276(2):626-36. PubMed ID: 8632330
[TBL] [Abstract][Full Text] [Related]
18. Different roles of dopamine receptor subtypes in footshock stress-induced enhancement of morphine conditioned place preference.
Dai Z; Kang L; Wang L; Ma L
Neurosci Lett; 2006 Nov; 409(1):52-6. PubMed ID: 17000048
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic- and antidepressant-like effects of 7-OH-DPAT, preferential dopamine D3 receptor agonist, in rats.
Rogóz Z; Skuza G; Kłlodzińska A
Pol J Pharmacol; 2004; 56(5):519-26. PubMed ID: 15591639
[TBL] [Abstract][Full Text] [Related]
20. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.
Lysle DT; Coussons ME; Watts VJ; Bennett EH; Dykstra LA
J Pharmacol Exp Ther; 1993 Jun; 265(3):1071-8. PubMed ID: 7685383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
